Document is current
Any future updates will be listed below
-
Authors
Keywani, K.
Eshuis, W. J.
Borgstein, A. B. J.
van Det, M. J.
van Duijvendijk, P.
van Etten, B.
Grimminger, P. P.
Heisterkamp, J.
Lagarde, S. M.
Luyer, M. D. P.
Markar, S. R.
Meijer, S. L.
Pierie, J. P. E. N.
Roviello, F.
Ruurda, J. P.
van Sandick, J. W.
Sosef, M.
Witteman, B. P. L.
de Steur, W. O.
Lissenberg-Witte, B. I.
van Berge Henegouwen, M. I.
Gisbertz, S. S.
- License Information
-
More Information
Article History
Received: 8 December 2023
Accepted: 12 August 2024
First Online: 4 September 2024
Declarations
:
: This study was approved by the Medical Ethics Review Committee (METC) of the Amsterdam UMC (NL80328.029.22). This trial was registered on 6<sup>th</sup> January 2022, in the ClinicalTrials.gov register under identification number NCT05180864. Patients can only participate if written informed consent has been provided.
: All authors read and approved the final study protocol and are fully aware of this publication. The study protocol does not contain any individual patient data.
: All authors declare that they have no competing interests.
